Key result
Chronic AF is linked to elevated IL-6, CRP, tissue factor, and plasma viscosity versus controls.
Why the study?
AF is associated with a prothrombotic state, but the role of inflammation in this pathophysiology has not been studied in detail.
Are inflammation markers (IL-6, CRP) associated with a prothrombotic state in patients with chronic atrial fibrillation?
Cross-Sectional (n=147)
Are inflammation markers (IL-6, CRP) associated with a prothrombotic state in patients with chronic atrial fibrillation?
p-value: p=0.034 for IL-6; 0.003 for CRP
Inflammation markers (IL-6, CRP) are elevated in chronic AF and correlate with prothrombotic markers, but this relationship may be driven by underlying vascular disease and comorbidities rather than AF itself.
Should not change AF management; hypothesis-generating for inflammation's independent role in stroke risk.
OBJECTIVES: We sought to test the hypothesis that there is a relationship between inflammation and the prothrombotic state in atrial fibrillation (AF). BACKGROUND: Atrial fibrillation is associated with a prothrombotic or hypercoagulable state, which may contribute to an increased risk of stroke and thromboembolism. Inflammation may be involved in the pathogenesis of AF, but the role of inflammation in the pathophysiology of the prothrombotic state of AF has not been studied in detail, despite evidence of a link between inflammation and arterial atherothrombotic disorders. METHODS: We measured plasma indexes of inflammation (C-reactive protein [CRP] and interleukin-6 [IL-6]) and the prothrombotic state, including markers of platelet activation (soluble P-selectin), endothelial damage/dysfunction (von Willebrand factor), the coagulation cascade (tissue factor [TF], fibrinogen), and indexes of blood rheology (plasma viscosity, plasma fibrinogen, and hematocrit) in 106 patients with chronic AF and 41 healthy control subjects included in a cross-sectional analysis. RESULTS: Compared with controls, AF patients had higher levels of IL-6 (p = 0.034), CRP (p = 0.003), TF (p = 0.019), and plasma viscosity (p = 0.045). Plasma IL-6 levels were higher among AF patients at "high" risk of stroke (p = 0.003). After adjusting for potential confounding clinical variables (e.g., vascular disease), AF remained significantly associated with a raised logarithmic transformation (log) of TF (p = 0.04), but the relationships between AF and log IL-6, log CRP, and plasma viscosity became nonsignificant. Among AF patients, log TF (p < 0.001) and high stroke risk (p = 0.003) were independent associates of log IL-6 (adjusted r(2) = 0.443), whereas log fibrinogen (p < 0.001) and plasma viscosity (p = 0.04) were independent associates of log CRP (adjusted r(2) = 0.259). CONCLUSIONS: Increased plasma IL-6, CRP, and plasma viscosity support the case for the existence of an inflammatory state among "typical" populations with chronic AF. These indexes of inflammation are related to indexes of the prothrombotic state and may be related to the clinical variables of the patients (underlying vascular disease and co-morbidities), rather than simply to the presence of AF itself.
No takes yet. Share an insight, caveat, or question.
Conway et al. (2004) conducted a cross-sectional in chronic atrial fibrillation (n=147). Chronic atrial fibrillation vs. Healthy control subjects was evaluated on Plasma indexes of inflammation (IL-6, CRP) and the prothrombotic state (tissue factor, plasma viscosity) (p=0.034 for IL-6; 0.003 for CRP). Chronic atrial fibrillation was associated with higher levels of IL-6 (p=0.034), CRP (p=0.003), tissue factor (p=0.019), and plasma viscosity (p=0.045) compared to healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: